Francesca Raffiotta

Changing patterns in clinical–histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis

Gabriella Moroni, Paolo Gilles Vercelloni, Silvana Quaglini et al. · Annals of the Rheumatic Diseases · 2018 · 201 citations · Full text

Medicine, Nephrology, Pathology +11

Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry.

Luca Iaccarino, Elena Bartoloni, Linda Carli et al. · PubMed · 2015 · 109 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

The Value of a Panel of Autoantibodies for Predicting the Activity of Lupus Nephritis at Time of Renal Biopsy

Gabriella Moroni, Silvana Quaglini, Antonella Radice et al. · Journal of Immunology Research · 2015 · 96 citations · Full text

Life Sciences, Immunology, Nephrology +17

Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study

Gabriella Moroni, Francesca Raffiotta, Barbara Trezzi et al. · Lara D. Veeken · 2014 · 92 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Low-dose rituximab is poorly effective in patients with primary membranous nephropathy

Gabriella Moroni, Federica Depetri, Lucia Del Vecchio et al. · Nephrology Dialysis Transplantation · 2016 · 69 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +11